ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Accounts Receivable of $1.91 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$6.95M, a 193.02% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$203.19M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $212.05M, a 8381.84% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $47.13M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $56.97M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$1.41M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$8.85M, a 194.01% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed | Increase (Decrease) in Accounts Receivable 125 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | -$210.14M derived: sum of 2 quarters · filed 2026-08-04 | $1.91M 10-Q · filed 2026-08-04 | $49.03M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2026-03-31 | -$203.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $8.86M 10-Q · filed 2026-05-07 | $55.99M derived: sum of 3 quarters · filed 2026-05-07 | $63.46M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-12-31 | $212.05M 10-Q · filed 2026-02-05 | $259.17M derived: sum of 2 quarters · filed 2026-02-05 | $266.65M derived: sum of 3 quarters · filed 2026-08-04 | $266.51M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-09-30 | $47.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $54.60M derived: sum of 2 quarters · filed 2026-08-04 | $54.47M derived: sum of 3 quarters · filed 2026-08-04 | $56.97M 10-K · filed 2025-11-25 | |||||
| 2025-06-30 | $7.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | $7.34M derived: sum of 2 quarters · filed 2026-08-04 | $9.84M 10-Q · filed 2026-08-04 | $9.84M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-03-31 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $2.37M 10-Q · filed 2026-05-07 | $2.37M derived: sum of 3 quarters · filed 2026-05-07 | $2.37M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $2.50M 10-Q · filed 2026-02-05 | $2.50M derived: sum of 2 quarters · filed 2026-02-05 | $2.50M derived: sum of 3 quarters · filed 2026-02-05 | $2.50M derived: sum of 4 quarters · filed 2026-02-05 | |||||
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $0.00 derived: sum of 2 quarters · filed 2025-11-25 | $0.00 derived: sum of 3 quarters · filed 2025-11-25 | $0.00 10-K · filed 2025-11-25 | |||||
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $0.00 derived: sum of 2 quarters · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | -$1.25M derived: sum of 4 quarters · filed 2025-11-25 | |||||
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-12 | $0.00 10-Q · filed 2025-05-12 | -$1.25M derived: sum of 3 quarters · filed 2025-11-25 | -$69.43M derived: sum of 4 quarters · filed 2025-11-25 | |||||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-10 | -$1.25M derived: sum of 2 quarters · filed 2025-11-25 | -$69.43M derived: sum of 3 quarters · filed 2025-11-25 | -$39.57M derived: sum of 4 quarters · filed 2025-11-25 | |||||
| 2023-09-30 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$69.43M derived: sum of 2 quarters · filed 2025-11-25 | -$39.57M derived: sum of 3 quarters · filed 2025-11-25 | -$1.41M 10-K · filed 2025-11-25 | |||||
| 2023-06-30 | -$68.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | -$38.32M derived: sum of 2 quarters · filed 2024-08-08 | -$164.00K 10-Q · filed 2024-08-08 | $1.01M derived: sum of 4 quarters · filed 2024-11-26 | |||||
| 2023-03-31 | $29.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $68.02M 10-Q · filed 2024-05-09 | $69.19M derived: sum of 3 quarters · filed 2024-11-26 | $68.12M derived: sum of 4 quarters · filed 2024-11-26 | |||||
| 2022-12-31 | $38.16M 10-Q · filed 2024-02-06 | $39.33M derived: sum of 2 quarters · filed 2024-11-26 | $38.25M derived: sum of 3 quarters · filed 2024-11-26 | $39.42M derived: sum of 4 quarters · filed 2024-11-26 | |||||
| 2022-09-30 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $93.00K derived: sum of 2 quarters · filed 2024-11-26 | $1.26M derived: sum of 3 quarters · filed 2024-11-26 | -$8.85M 10-K · filed 2024-11-26 | |||||
| 2022-06-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | $89.00K derived: sum of 2 quarters · filed 2023-08-07 | -$10.02M 10-Q · filed 2023-08-07 | -$433.00K derived: sum of 4 quarters · filed 2023-11-29 | |||||
| 2022-03-31 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | -$8.94M 10-Q · filed 2023-05-02 | $645.00K derived: sum of 3 quarters · filed 2023-11-29 | $362.00K derived: sum of 4 quarters · filed 2023-11-29 | |||||
| 2021-12-31 | -$10.11M 10-Q · filed 2023-02-06 | -$522.00K derived: sum of 2 quarters · filed 2023-11-29 | -$805.00K derived: sum of 3 quarters · filed 2023-11-29 | -$8.85M derived: sum of 4 quarters · filed 2023-11-29 | |||||
| 2021-09-30 | $9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $9.30M derived: sum of 2 quarters · filed 2023-11-29 | $1.25M derived: sum of 3 quarters · filed 2023-11-29 | $9.41M 10-K · filed 2023-11-29 | |||||
| 2021-06-30 | -$283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | -$8.33M derived: sum of 2 quarters · filed 2022-08-04 | -$174.00K 10-Q · filed 2022-08-04 | -$21.02M derived: sum of 4 quarters · filed 2022-11-28 | |||||
| 2021-03-31 | -$8.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $109.00K 10-Q · filed 2022-05-10 | -$20.74M derived: sum of 3 quarters · filed 2022-11-28 | -$311.00K derived: sum of 4 quarters · filed 2022-11-28 | |||||
| 2020-12-31 | $8.16M 10-Q · filed 2022-02-02 | -$12.69M derived: sum of 2 quarters · filed 2022-11-28 | $7.74M derived: sum of 3 quarters · filed 2022-11-28 | $7.66M derived: sum of 4 quarters · filed 2022-11-28 | |||||
| 2020-09-30 | -$20.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$420.00K derived: sum of 2 quarters · filed 2022-11-28 | -$500.00K derived: sum of 3 quarters · filed 2022-11-28 | $184.00K 10-K · filed 2022-11-28 | $184.31K 10-K · filed 2020-11-23 | ||||
| 2020-06-30 | $20.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $20.35M derived: sum of 2 quarters · filed 2021-08-05 | $21.03M 10-Q · filed 2021-08-05 | $21.03M 10-Q · filed 2020-08-05 | $19.65M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2020-03-31 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04 | $604.00K 10-Q · filed 2021-05-04 | $604.41K 10-Q · filed 2020-05-07 | -$778.74K derived: sum of 3 quarters · filed 2021-11-22 | -$12.16M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2019-12-31 | $684.00K 10-Q · filed 2021-02-04 | $683.94K 10-Q · filed 2020-02-05 | -$698.74K derived: sum of 2 quarters · filed 2021-11-22 | -$12.08M derived: sum of 3 quarters · filed 2021-11-22 | -$1.82M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2019-09-30 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | -$12.76M derived: sum of 2 quarters · filed 2021-11-22 | -$2.51M derived: sum of 3 quarters · filed 2021-11-22 | $334.00K 10-K · filed 2021-11-22 | $333.99K 10-K · filed 2019-11-25 | ||||
| 2019-06-30 | -$11.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | -$1.12M derived: sum of 2 quarters · filed 2020-08-05 | $1.72M 10-Q · filed 2020-08-05 | $2.03M derived: sum of 4 quarters · filed 2020-11-23 | |||||
| 2019-03-31 | $10.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $13.09M 10-Q · filed 2020-05-07 | $13.41M derived: sum of 3 quarters · filed 2020-11-23 | $13.41M derived: sum of 4 quarters · filed 2020-11-23 | |||||
| 2018-12-31 | $2.84M 10-Q · filed 2020-02-05 | $3.15M derived: sum of 2 quarters · filed 2020-11-23 | $3.15M derived: sum of 3 quarters · filed 2020-11-23 | $3.02M derived: sum of 4 quarters · filed 2020-11-23 | |||||
| 2018-09-30 | $312.40K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | $311.09K derived: sum of 2 quarters · filed 2020-11-23 | $177.44K derived: sum of 3 quarters · filed 2020-11-23 | $259.58K 10-K · filed 2020-11-23 | |||||
| 2018-06-30 | -$1.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | -$134.96K derived: sum of 2 quarters · filed 2019-08-05 | -$52.82K 10-Q · filed 2019-08-05 | -$922.34K derived: sum of 4 quarters · filed 2019-11-25 | |||||
| 2018-03-31 | -$133.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | -$51.51K 10-Q · filed 2019-05-08 | -$921.03K derived: sum of 3 quarters · filed 2019-11-25 | -$564.54K derived: sum of 4 quarters · filed 2019-11-25 | |||||
| 2017-12-31 | $82.13K 10-Q · filed 2019-02-07 | -$787.38K derived: sum of 2 quarters · filed 2019-11-25 | -$430.89K derived: sum of 3 quarters · filed 2019-11-25 | $89.93K derived: sum of 4 quarters · filed 2019-11-25 | |||||
| 2017-09-30 | -$869.52K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | -$513.03K derived: sum of 2 quarters · filed 2019-11-25 | $7.80K derived: sum of 3 quarters · filed 2019-11-25 | -$7.20K 10-K · filed 2019-11-25 | |||||
| 2017-06-30 | $356.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | $877.31K derived: sum of 2 quarters · filed 2018-08-07 | $862.31K 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | $520.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | $505.82K 10-Q · filed 2018-05-08 | |||||||
| 2016-12-31 | -$15.00K 10-Q · filed 2018-02-09 | ||||||||
| 2016-09-30 | $75.00K 10-K · filed 2018-12-11 | ||||||||
| 2016-03-31 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03 | $25.16K 10-Q · filed 2017-05-03 | |||||||
| 2015-12-31 | $1.05M 10-Q · filed 2017-02-06 | ||||||||
| 2014-09-30 | -$75.00K 10-K · filed 2016-12-14 | ||||||||
| 2013-09-30 | $65.63K 10-K · filed 2014-11-25 | -$34.41K 10-K · filed 2013-12-18 | |||||||
| 2012-09-30 | -$162.85K 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |